The first sign of Pfizer’s eagerness to do a deal with Australia came in the middle of last year. A letter from Pfizer, dated 30 June, invited Australian government officials for discussions about its mRNA vaccine – at that stage still in development.
A meeting was scheduled within a fortnight. It was the first of a series of 11 formal meetings and ad hoc phone calls between Pfizer and Australian officials.
The first, on 10 July, has been the subject of intense controversy. In the room were Pfizer’s Australian executives and a group of government lawyers and senior health officials, including Lisa Schofield, the first assistant secretary in the government’s Covid taskforce.
“Pfizer said: ‘This is a vaccine that we are developing,’ ” Schofield told a Senate inquiry. “We said that we were interested in talking to them about potentially purchasing that vaccine, but that was it. No numbers or details were put on the table at that discussion on 10 July.”
But a different account has emerged in the reporting of Norman Swan, the host of the ABC’s Coronacast podcast. Citing unnamed sources,
he reported that one Australian official was belligerent, tried to haggle over the price, and demanded access to intellectual property. The conversations continued but no deal was struck, in his account.
Then acting Victorian premier James Merlino has also spoken of a huge offer made by Pfizer to the Australian government at the time of the first meeting.
“Our nation had a ‘sliding doors’ moment last July,”
he said. “Last July, there was an offer of Pfizer to the commonwealth government that would be enough for our country, and they didn’t take it up.”